Nutex Health Inc. (NASDAQ:NUTX) Short Interest Update

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) was the recipient of a significant decline in short interest in January. As of January 31st, there was short interest totalling 29,100 shares, a decline of 43.5% from the January 15th total of 51,500 shares. Based on an average daily volume of 48,200 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.9% of the shares of the stock are sold short.

Institutional Trading of Nutex Health

Large investors have recently added to or reduced their stakes in the stock. Bank of America Corp DE grew its holdings in Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares in the last quarter. Beaird Harris Wealth Management LLC purchased a new position in shares of Nutex Health during the 3rd quarter worth $69,000. Northern Trust Corp purchased a new position in shares of Nutex Health during the 4th quarter worth $200,000. Baader Bank Aktiengesellschaft purchased a new position in shares of Nutex Health during the 4th quarter worth $206,000. Finally, Millennium Management LLC purchased a new position in shares of Nutex Health during the 4th quarter worth $213,000. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

Nutex Health Trading Down 1.9 %

NASDAQ:NUTX traded down $1.30 during trading hours on Monday, hitting $66.06. The company had a trading volume of 36,755 shares, compared to its average volume of 42,467. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. The company has a 50-day moving average of $39.62 and a 200 day moving average of $29.04. The company has a market cap of $359.17 million, a P/E ratio of -7.04 and a beta of 0.20. Nutex Health has a 1 year low of $4.16 and a 1 year high of $69.45.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on NUTX. Benchmark boosted their price target on Nutex Health from $45.00 to $60.00 and gave the stock a "buy" rating in a research report on Tuesday, November 12th. Maxim Group upped their target price on Nutex Health from $50.00 to $75.00 and gave the company a "buy" rating in a report on Thursday.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.